We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Tocilizumab for Relapsing Polychondritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01104480
Recruitment Status : Withdrawn (Tocilizumab was licenced in Canada for children, so the study was not necessary)
First Posted : April 15, 2010
Last Update Posted : May 13, 2014
Information provided by (Responsible Party):
Dr Maggie Larche, McMaster Children's Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : July 2010
  Estimated Study Completion Date : May 2012